NCT01670071 A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia Status TERMINATED Phase PHASE4
NCT01663532 Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia Status COMPLETED Phase PHASE3
NCT01663077 Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients Status COMPLETED Phase PHASE4
NCT01662648 Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT01662310 An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT01658150 Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase NA
NCT01655680 A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia Status COMPLETED Phase PHASE2
NCT01655368 Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM) Status COMPLETED Phase NA
NCT01654640 The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine Status TERMINATED Phase PHASE4
NCT01654601 A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg Status COMPLETED Phase PHASE1
NCT01646827 An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01634542 An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia Status COMPLETED Phase N/A